Etofenamate

依托芬那酯

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEtofenamate
Drug Alias Name氟灭酸酯etofenamato依托非那酯etofenamatumBay-d-1107 +[6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsPainInflammation
Global Approved IndicationsPainInflammation
Approved Indications in ChinaPainInflammation
Original Approved Country/TerritoryMainland China
Original Approved Date1999/03/25
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesN/A
Active IndicationsPainInflammation
Inactive IndicationsN/A

Other Information

ATC CodeM02AA06